115 related articles for article (PubMed ID: 9176204)
1. Hepatobiliary transport mechanism for the cyclopentapeptide endothelin antagonist BQ-123.
Shin HC; Kato Y; Yamada T; Niinuma K; Hisaka A; Sugiyama Y
Am J Physiol; 1997 May; 272(5 Pt 1):G979-86. PubMed ID: 9176204
[TBL] [Abstract][Full Text] [Related]
2. Primary active transport of peptidic endothelin antagonists by rat hepatic canalicular membrane.
Akhteruzzaman S; Kato Y; Hisaka A; Sugiyama Y
J Pharmacol Exp Ther; 1999 Feb; 288(2):575-81. PubMed ID: 9918561
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary transport governs overall elimination of peptidic endothelin antagonists in rats.
Kato Y; Akhteruzzaman S; Hisaka A; Sugiyama Y
J Pharmacol Exp Ther; 1999 Feb; 288(2):568-74. PubMed ID: 9918560
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective hepatobiliary transport of the quinolone antibiotic grepafloxacin and its glucuronide in the rat.
Sasabe H; Kato Y; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1998 Feb; 284(2):661-8. PubMed ID: 9454812
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
[TBL] [Abstract][Full Text] [Related]
6. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
Yamazaki M; Kobayashi K; Sugiyama Y
Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary transport of a nonpeptidic endothelin antagonist, (+)-(5S,6R,7R)-2-butyl-7-[2((2S)-2-carboxypropyl)-4-methoxyphenyl]-5-(3,4-methylenedioxyphenyl) cyclopentenol[1,2-b]pyridine-6-carboxylic acid: uptake by isolated rat hepatocytes and canalicular membrane vesicles.
Kobayashi N; Tani T; Hisaka A; Hara K; Yasumori T
Pharm Res; 2003 Jan; 20(1):89-95. PubMed ID: 12608541
[TBL] [Abstract][Full Text] [Related]
8. Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats.
Fernández-Checa JC; Takikawa H; Horie T; Ookhtens M; Kaplowitz N
J Biol Chem; 1992 Jan; 267(3):1667-73. PubMed ID: 1730711
[TBL] [Abstract][Full Text] [Related]
9. Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats.
Chu XY; Kato Y; Niinuma K; Sudo KI; Hakusui H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Apr; 281(1):304-14. PubMed ID: 9103511
[TBL] [Abstract][Full Text] [Related]
10. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.
Yamazaki M; Akiyama S; Ni'inuma K; Nishigaki R; Sugiyama Y
Drug Metab Dispos; 1997 Oct; 25(10):1123-9. PubMed ID: 9321514
[TBL] [Abstract][Full Text] [Related]
11. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats.
Yamazaki M; Kobayashi K; Sugiyama Y
Biopharm Drug Dispos; 1996 Nov; 17(8):645-59. PubMed ID: 8950045
[TBL] [Abstract][Full Text] [Related]
12. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
Han YH; Kato Y; Watanabe Y; Terao K; Asoh Y; Sugiyama Y
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver. Possible roles of P-glycoprotein in biliary excretion of vincristine.
Watanabe T; Miyauchi S; Sawada Y; Iga T; Hanano M; Inaba M; Sugiyama Y
J Hepatol; 1992 Sep; 16(1-2):77-88. PubMed ID: 1362433
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia.
Takenaka O; Horie T; Kobayashi K; Suzuki H; Sugiyama Y
Pharm Res; 1995 Nov; 12(11):1746-55. PubMed ID: 8592681
[TBL] [Abstract][Full Text] [Related]
15. Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats. Comparison between in vivo and in vitro.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
Drug Metab Dispos; 1997 May; 25(5):536-43. PubMed ID: 9152591
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
Sathirakul K; Suzuki H; Yasuda K; Hanano M; Tagaya O; Horie T; Sugiyama Y
J Pharmacol Exp Ther; 1993 Jun; 265(3):1301-12. PubMed ID: 8510010
[TBL] [Abstract][Full Text] [Related]
17. Carrier-mediated hepatic uptake of peptidic endothelin antagonists in rats.
Akhteruzzaman S; Kato Y; Kouzuki H; Suzuki H; Hisaka A; Stieger B; Meier PJ; Sugiyama Y
J Pharmacol Exp Ther; 1999 Sep; 290(3):1107-15. PubMed ID: 10454484
[TBL] [Abstract][Full Text] [Related]
18. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.
Sasabe H; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864
[TBL] [Abstract][Full Text] [Related]
19. Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
Nakamura T; Hisaka A; Sawasaki Y; Suzuki Y; Fukami T; Ishikawa K; Yano M; Sugiyama Y
J Pharmacol Exp Ther; 1996 Aug; 278(2):564-72. PubMed ID: 8768705
[TBL] [Abstract][Full Text] [Related]
20. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).
Ishizuka H; Konno K; Naganuma H; Sasahara K; Kawahara Y; Niinuma K; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
